11 results
How does the 2019 Novel Coronavirus (nCoV2019) compare to Ebola, SARS, MERS? Cases and Deaths
Weighing diseases
(nCoV2019) compare ... into perspective. nCoV2019 ... remains stable ... Vaccinologist #nCoV2019 ... #COVID19
Case Fatality Rate (CFR) and R0 of the Novel Coronavirus 2019 compared to other famous contagious
Case Fatality Rate ... R0 of the Novel Coronavirus ... contagious virues #Coronavirus ... #COVID19 #NCOV2019
Brief Overview of Treatment Agents for COVID-19 - Version 2.01 4/11/2020

#Drugs #Medications #Treatment #COVID19 #Pharmacology #Table
Brief Overview of ... Treatment Agents for COVID ... Medications #Treatment #COVID19 ... #Pharmacology # ... Table #Management
Reproductive Number (R0 "R Naught") showing how contagious / transmissible a pathogen is.  The R0
The R0 for Wuhan nCoV2019 ... Ebola) and their case-fatality ... RNaught #Contagious #nCoV2019 ... #table #SARS #Ebola ... contagiousness #COVID19
Criteria for Patients Under Investigation for 2019 Novel Coronavirus (2019-nCoV) / COVID-19

Fever or signs/symptoms of lower
for 2019 Novel Coronavirus ... (2019-nCoV) / COVID ... symptoms of lower respiratory ... Investigation #Novel #Coronavirus ... #nCoV2019 #COVID19
Ivermectin. Old anti-parasitic agent making a comeback with recent headlines from in-vitro study that showed antiviral
virus causing COVID ... here is a quick overview ... ivermectin… #COVID19 ... #Coronavirus #SARS-CoV ... EmergencyMedicine #Pharmacology
Simplified Representation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Lifecycle and Potential Drug Targets

#Therapeutic
of Severe Acute Respiratory ... Syndrome Coronavirus ... Therapeutic #Targets #Pharmacology ... #SARSCOV2 #Coronavirus ... #COVID19 #JAMA
Summary of Pharmacology for Select Proposed COVID-19 Treatments

#Pharmacology #Dosing #Table #COVID19 #Coronavirus #SARSCOV2 #Medications #JAMA
Summary of Pharmacology ... Select Proposed COVID ... Treatments #Pharmacology ... #Dosing #Table ... #COVID19 #Coronavirus
UCSF COVID-19 Adult Clinical Evaluation Guide - Updated April 10 2020

Clinical Presentation
• Fever: hospitalized pts but
UCSF COVID-19 Adult ... Myalgias 10-50% • Respiratory ... Cardiac: multiple case ... Jen Babik, UCSF COVID ... Protocol #SARSCoV2 #Coronavirus
Persistence of clinically relevant viruses on dry inanimate surfaces

Most common viruses persist on surfaces for days
The novel coronavirus ... days to 3 months Coronavirus ... infectiousdiseases #diagnosis #table ... contagiousness #COVID19 ... #ncov2019